Literature DB >> 19822292

Making the case for molecular staging of malignant pleural mesothelioma.

Raphael Bueno1.   

Abstract

Malignant pleural mesothelioma is an aggressive malignancy for which surgical treatment is an option for a subset of patients. A gene ratio test based on the relative expression levels of four genes has been validated in clinical trials to predict which patients will benefit from surgical therapy. A description of the test properties and the independent predictors for outcome are provided.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19822292      PMCID： PMC2904964          DOI： 10.1053/j.semtcvs.2009.07.003

Source DB:  PubMed          Journal:  Semin Thorac Cardiovasc Surg        ISSN： 1043-0679


  54 in total

1.  Limits of predictive models using microarray data for breast cancer clinical treatment outcome.

Authors:  James F Reid; Lara Lusa; Loris De Cecco; Danila Coradini; Silvia Veneroni; Maria Grazia Daidone; Manuela Gariboldi; Marco A Pierotti
Journal:  J Natl Cancer Inst       Date:  2005-06-15       Impact factor: 13.506

Review 2.  Microarray analysis and tumor classification.

Authors:  John Quackenbush
Journal:  N Engl J Med       Date:  2006-06-08       Impact factor: 91.245

3.  Validation of genomics-based prognostic tests in malignant pleural mesothelioma.

Authors:  Gavin J Gordon; Graham N Rockwell; Paul A Godfrey; Roderick V Jensen; Jonathan N Glickman; Beow Y Yeap; William G Richards; David J Sugarbaker; Raphael Bueno
Journal:  Clin Cancer Res       Date:  2005-06-15       Impact factor: 12.531

4.  A proposed new international TNM staging system for malignant pleural mesothelioma. From the International Mesothelioma Interest Group.

Authors:  V W Rusch
Journal:  Chest       Date:  1995-10       Impact factor: 9.410

5.  Predicting prostate cancer risk through incorporation of prostate cancer gene 3.

Authors:  Donna Pauler Ankerst; Jack Groskopf; John R Day; Amy Blase; Harry Rittenhouse; Brad H Pollock; Cathy Tangen; Dipen Parekh; Robin J Leach; Ian Thompson
Journal:  J Urol       Date:  2008-08-15       Impact factor: 7.450

6.  Prevention, early detection, and management of complications after 328 consecutive extrapleural pneumonectomies.

Authors:  David J Sugarbaker; Michael T Jaklitsch; Raphael Bueno; William Richards; Jeanne Lukanich; Steven J Mentzer; Yolonda Colson; Phillip Linden; Michael Chang; Leah Capalbo; Elizabeth Oldread; Siyamek Neragi-Miandoab; Scott J Swanson; Lambros S Zellos
Journal:  J Thorac Cardiovasc Surg       Date:  2004-07       Impact factor: 5.209

7.  Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients.

Authors:  Raja M Flores; Harvey I Pass; Venkatraman E Seshan; Joseph Dycoco; Maureen Zakowski; Michele Carbone; Manjit S Bains; Valerie W Rusch
Journal:  J Thorac Cardiovasc Surg       Date:  2008-02-14       Impact factor: 5.209

Review 8.  Advances in the molecular biology of malignant mesothelioma.

Authors:  Shinichi Toyooka; Takumi Kishimoto; Hiroshi Date
Journal:  Acta Med Okayama       Date:  2008-02       Impact factor: 0.892

9.  Asbestos exposure predicts cell cycle control gene promoter methylation in pleural mesothelioma.

Authors:  Brock C Christensen; John J Godleski; Carmen J Marsit; E A Houseman; Cristina Y Lopez-Fagundo; Jennifer L Longacker; Raphael Bueno; David J Sugarbaker; Heather H Nelson; Karl T Kelsey
Journal:  Carcinogenesis       Date:  2008-02-28       Impact factor: 4.944

10.  Gene expression profiling of the tumor microenvironment during breast cancer progression.

Authors:  Xiao-Jun Ma; Sonika Dahiya; Elizabeth Richardson; Mark Erlander; Dennis C Sgroi
Journal:  Breast Cancer Res       Date:  2009-02-02       Impact factor: 6.466
View more
  1 in total

Review 1.  Malignant pleural mesothelioma: predictors and staging.

Authors:  William G Richards
Journal:  Ann Transl Med       Date:  2017-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.